241 related articles for article (PubMed ID: 35693235)
1. Pyridine: the scaffolds with significant clinical diversity.
De S; Kumar S K A; Shah SK; Kazi S; Sarkar N; Banerjee S; Dey S
RSC Adv; 2022 May; 12(24):15385-15406. PubMed ID: 35693235
[TBL] [Abstract][Full Text] [Related]
2. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications.
Kerru N; Gummidi L; Maddila S; Gangu KK; Jonnalagadda SB
Molecules; 2020 Apr; 25(8):. PubMed ID: 32326131
[TBL] [Abstract][Full Text] [Related]
3. Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry.
Song Y; Zhan P; Zhang Q; Liu X
Curr Pharm Des; 2013; 19(8):1528-48. PubMed ID: 23131184
[TBL] [Abstract][Full Text] [Related]
4. The Expanding Role of Pyridine and Dihydropyridine Scaffolds in Drug Design.
Ling Y; Hao ZY; Liang D; Zhang CL; Liu YF; Wang Y
Drug Des Devel Ther; 2021; 15():4289-4338. PubMed ID: 34675489
[TBL] [Abstract][Full Text] [Related]
5. Syntheses and medicinal chemistry of azepinoindolones: a look back to leap forward.
Kadagathur M; Patra S; Sigalapalli DK; Shankaraiah N; Tangellamudi ND
Org Biomol Chem; 2021 Jan; 19(4):738-764. PubMed ID: 33459333
[TBL] [Abstract][Full Text] [Related]
6. Pyrrolo[2,1-f][1,2,4]triazines: From C-nucleosides to kinases and back again, the remarkable journey of a versatile nitrogen heterocycle.
Ott GR; Favor DA
Bioorg Med Chem Lett; 2017 Sep; 27(18):4238-4246. PubMed ID: 28801135
[TBL] [Abstract][Full Text] [Related]
7. The emergence of the C-H functionalization strategy in medicinal chemistry and drug discovery.
Jana R; Begam HM; Dinda E
Chem Commun (Camb); 2021 Oct; 57(83):10842-10866. PubMed ID: 34596175
[TBL] [Abstract][Full Text] [Related]
8. Current advances in the synthetic strategies of 2-arylbenzothiazole.
Sethiya A; Sahiba N; Teli P; Soni J; Agarwal S
Mol Divers; 2022 Feb; 26(1):513-553. PubMed ID: 33180241
[TBL] [Abstract][Full Text] [Related]
9. The chemistry and biological activity of heterocycle-fused quinolinone derivatives: A review.
Shiro T; Fukaya T; Tobe M
Eur J Med Chem; 2015 Jun; 97():397-408. PubMed ID: 25532473
[TBL] [Abstract][Full Text] [Related]
10. Medicinal Attributes of Imidazo[1,2-a]pyridine Derivatives: An Update.
Devi N; Singh D; Rawal RK; Bariwal J; Singh V
Curr Top Med Chem; 2016; 16(26):2963-2994. PubMed ID: 27150367
[TBL] [Abstract][Full Text] [Related]
11. Scaffold diversity of exemplified medicinal chemistry space.
Langdon SR; Brown N; Blagg J
J Chem Inf Model; 2011 Sep; 51(9):2174-85. PubMed ID: 21877753
[TBL] [Abstract][Full Text] [Related]
12. Indole and Indoline Scaffolds in Antimicrobials: Overview, Synthesis and Recent Advances in Antimicrobial Research.
Nieto MJ; Lupton HK
Curr Med Chem; 2021; 28(24):4828-4844. PubMed ID: 33138747
[TBL] [Abstract][Full Text] [Related]
13. Natural products as starting points for future anti-malarial therapies: going back to our roots?
Wells TN
Malar J; 2011 Mar; 10 Suppl 1(Suppl 1):S3. PubMed ID: 21411014
[TBL] [Abstract][Full Text] [Related]
14. Functionalized Benzimidazole Scaffolds: Privileged Heterocycle for Drug Design in Therapeutic Medicine.
Ajani OO; Aderohunmu DV; Ikpo CO; Adedapo AE; Olanrewaju IO
Arch Pharm (Weinheim); 2016 Jul; 349(7):475-506. PubMed ID: 27213292
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic Activities of 5, 6-Diaryl/heteroaryl-3-substituted-1, 2, 4- triazines as a Privileged Scaffold in Drug Development.
Khatir ZZ; Irannejad H
Mini Rev Med Chem; 2021; 21(19):2874-2928. PubMed ID: 33719962
[TBL] [Abstract][Full Text] [Related]
16. Thiazole: a promising heterocycle for the development of potent CNS active agents.
Mishra CB; Kumari S; Tiwari M
Eur J Med Chem; 2015 Mar; 92():1-34. PubMed ID: 25544146
[TBL] [Abstract][Full Text] [Related]
17. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.
Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA
Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996
[TBL] [Abstract][Full Text] [Related]
18. Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Biologically Active Agents.
Chiacchio MA; Iannazzo D; Romeo R; Giofrè SV; Legnani L
Curr Med Chem; 2019; 26(40):7166-7195. PubMed ID: 30182842
[TBL] [Abstract][Full Text] [Related]
19. Tailored Quinolines Demonstrate Flexibility to Exert Antitumor Effects through Varied Mechanisms-A Medicinal Perspective.
Sharma S; Singh A; Sharma S; Sharma R; Singh J; Kinarivala N; Nepali K; Liou JP
Anticancer Agents Med Chem; 2021; 21(3):288-315. PubMed ID: 32900354
[TBL] [Abstract][Full Text] [Related]
20. 1,3,4-thiadiazole: a privileged scaffold for drug design and development.
Han X; Yu YL; Hu YS; Liu XH
Curr Top Med Chem; 2021; 21(28):2546-2573. PubMed ID: 34766891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
